Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Second-line Therapies for Patients With Type 2 Diabetes and Moderate Cardiovascular Disease Risk

NCT05214573 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05214573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05214573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Second-line Therapies for Patients With Type 2 Diabetes and Moderate Cardiovascular Disease Risk
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
December 1, 2021
Completion date
July 22, 2025
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac disease, type 2 diabetes